Sprifermin: a recombinant human fibroblast growth factor 18 for the treatment of knee osteoarthritis

Li, J; Wang, XS; Ruan, GF; Zhu, ZH; Ding, CH

Ding, CH (corresponding author), Southern Med Univ, Zhujiang Hosp, Clin Res Ctr, Guangzhou, Peoples R China.; Ding, CH (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.; Ding, CH (corresponding author), Youjiang Med Univ Nationalities, Affiliated Hosp, Baise, Peoples R China.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021; 30 (9): 923